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Abstract

Introduction

Numerous synthetic biomaterials have been developed as vascular substitutes. In vitro, ex vivo
and in vivo studies have demonstrated that in animals , selected materials, i.e., Dacron and ePTFE
(expanded polytetrafluoroethylene) grafts, are successfully incorporated in both the large and the
small caliber host arteries through a process which is
generally referred to as graft healing. Morphologically, this process consists of a series of complex
events including fibrin deposition and degradation,
monocyte-macrophage recruitment and flow-oriented
cell-layer generation, this last event being the
complete endothelialization of the arterial substitute.
In contrast to experimental animals, the flow
surface of synthetic vascular grafts remains unhealed
in humans, particularly in the small caliber conduits.
Healing in man consists of graft incorporation by the
perigraft fibrous tissue response with a surface covered by more or less compacted, cross-linked fibrin.
It is therefore obvious that: i) marked differences in graft healing exist between animals and
man; and ii) the usual mechanisms of graft endothelialization are partially ineffective in man.
In order to guarantee the patency of synthetic
vascular grafts for human small artery bypass, new
strategies and approaches have recently been attempted. In particular, the endothelial cell seeding
approach has been successfully accomplished in animals and is being experimented in human clinical
studies.
The problems and results of this biological
approach are outlined in this paper.

The incorporation of synthetic vascular grafts
in the host artery has been studied for a long time
by many investigators (8, 71, 74, 76). Features suggesting an efficient graft healing have been outlined
(12, 13 , 19, 30, 62, 69, 74) . It was subsequently sug gested that a neointimal coverage on the implanted
prosthetic material could significantly improve the
clinical performance of high-flow and even more of
low-flow small caliber grafts (7, 28, 79, 81). In par ticular, graft endothelialization is currently considered one of the essential factors influencing pat ency or occlusion of prosthetic grafts ( 7, 44, 81).
However, the promising experimental results have not
yet been confirmed in man (1, 7, 15, 24, 56, 76).
This study deals with the healing of synthetic
vascular grafts in animals and in humans. Particular
attention will be paid to the recent techniques of
seeding vascular grafts with endothelium.
Spontaneous Graft Healing in Animals
During the 1950s and early 1960s, Wesolowski
(74, 77) screened more than 300 different materials
in the growing pig and the adult dog. As a result of
a number of observations, a relative scale of biological acceptability was established, in which synthetic
materials occupied an intermediate position. During
the last few years, all but Dacron materials were rejected for different reasons. Thereafter , new biomaterials (e.g., expanded polytetrafluoroethylene,
ePTFE) have been introduced. These are the only
plastic materials used in large and small diameter
grafts in humans.
Dacron grafts
Morphological studies have made it possible to
define the basic pattern of Dacron healing and its
eventual complications.
Basically, Dacron heals
through an early fibrinous incorporation which is
gradually organized and converted into a tenacious
and firmly adherent fibrous capsule (74, 77).
The initial fibrin-implant complex is relatively
stable and can remain essentially unchanged for
weeks or even months, depending on the species of
animal utilized. Interestingly, fibrin organization by
granulation tissue requires a sufficient graft porosity
(19, 30, 62, 77).
From the beginning of its formation, the fibrin
lining is continuously undergoing intense rearrangements. The trapped leukocytes and particularly the
macrophages phagocytize fragments of fibrin and cell
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debris and release proteolytic enzymes which begin
to digest the protein-rich luminal coverage. Concurrently, fibroblasts and small blood vessels proliferate
and spread out through the graft interstices.
In
time, the entire fibrinous lining is converted into a
well-vascularized connective tissue. Fibrous tissue
contracts in the course of weeks to months. However, the grafts presents characteristic elasticity and
compliance which is not adequate enough to balance
the tensile strength generated by the normal scar
contraction. Particularly at the level of the graft
interstices, verification of a discrepancy between diverse tensile forces with consequent breakage and
thrombosis of capillary channels may occur. This
event may cause either a simple delay in the healing
process or may even induce a band of necrosis, in
areas where the healing phenomenon proves to be
particularly intense, followed by calcification directly
behind the prosthetic mesh. Complications of this
nature, concerning the healing graft process designated by Wesolowsky (77, and also quoted by Wesolow in 74) as inner capsule degeneration, is believed
to be responsible for early graft failure, including
perigraft seroma and hematoma and graft occlusion.
The rate of healing complications is inversely related
to graft porosity as described by the classic calcification index curve from Wesolowski (77).
Various authors have described endothelium on
the inner side of the prostheses with both fibroblasts
and smooth muscle cells forming the bulk of the underlying intima.
There is general agreement that
graft endothelialization may originate from the host
artery next to the suture lines (7). In contrast,
other authors claim that endothelium may derive
from capillary ingrowth into the graft interstices ( 12,
13) as well as from a blood source (22, 46, 52, 59).
In particular, Harker suggested that the endothelial
lining might be generated by endothelial microemboli
which may be present in the blood flow (26). Moreover, evidence of the transformation of mononuclear
cells into myofibroblasts and endothelial cells was
provided by Feigl et al. (18).
Most probably there is a variable contribution
of the different sources to the fully endothelialized
grafts. In general, the host artery represents the
most common source even though a kinetic study
suggests that it is not very effective ( 5 7) . In the
low porosity graft, a hyperplastic response develops
on the part of the artery to which the graft is su tured. This reaction is called pannus (1) and slowly
extends along the inner aspect of the prosthesis. By
transmission electron microscopy (TEM), the pannus
consists of undifferentiated mesenchymal cells, activated smooth muscle cells, fibroblasts and blood cells
embedded in a loose extracellular matrix (Fig. 1). At
surface level, the advancing edge of endothelial cells
while migrating towards the fibrinous lining can be
appreciated (48, 52). In the porous materials, the
granulation tissue allows the formation of numerous
blood vessels in the inner fibrinous aspect of the
graft. The capillaries migrating through the interstices of the prostheses can therefore provide multiple sources of endothelium at the luminal surface
(Fig. 2).
ePTFE (expanded polytetrafluoroethylene) grafts
ePTFE is a non-textile material which is hydrophobic at the time of insertion, gradually becomes
wet, and within 48 to 72 hours becomes filled with
fibrin and blood cells. The sequence of healing is

very similar to that of Dacron prosthese1 (8).
However, the ingrowth of fibroblast and c<llagen
tissue through the ePTFE pores proceeds more slowly
than in Dacron because of the low porosity of the
initially used materials. For the same reasm, the
endothelialization of conventional ePTFE gr a lt s ( 30
micrometers internodal distance) also proceed, very
slowly.
According to Clowes et al. (12), by 12
months only 60 % of the grafts 6-9 cm in lengt1 were
fully healed. Smooth muscle cells and endcthelial
cells were provided from anastomotic arterial smrces.
In a further study, Clowes et al. (13) provicbd the
evidence that an increase in graft porosity (60
micrometers internodal distance) can radicau, alter
the mechanisms of ePTFE healing. By scanninf elec tron microscopy ( SE M), a confluent layer of endothelial cells associated with multiple small capillary
orifices was observed within 2 weeks of ePT f E implantation, whereas a complete endothelial linbg was
obtained after 4 weeks in baboons. In this ex:perimental design, endothelium was provided by rapid
transmural capillary ingrowth through the graf1 pores
whereas smooth muscle cells most probably originated
from pericytes surrounding endothelial cells.
Compound prostheses
Compound arterial prostheses represent he latter advance in the field of graft manufacturin&. As
originally suggested by Wesolowski et al. (75) these
prostheses are composed of two or more substances,
where one of the components is readily resorbl.ble by
the body and the other one remains permanen . The
rationale for this design is to produce a material
that has a low or zero porosity, a consequent minimal controlled blood loss at implantation and a significantly higher porosity, due to resorption of the
biodegradable component at the time of the re::i.uired
healing.
Different combinations have been tested
with varying results.
Glutalardehyde - fixed albumin-coated Dacron
grafts have a very low porosity (100 ml / min/ cm2 ) at
implantation, but may be somewhat thrombogenic
(25). Heat-denatured albumin-coated Dacron grafts
produce better results.
These materials have a
smooth, homogeneous, well - fi x ed flow surface that is
apparently thromboresistant.
The heat - denatured
albumin is resorbed within 4 weeks after imrlantation, and long - term healing is not affected (61).
However, a delayed early tissue incorporation is
reported and no immediate advantages beside s the
initial low porosity are evident.
Wesolowski and associates screened nunerous
grafts in which the biodegradable component was
collagen (75).
Most of these materials developed
aneurysms and subsequent hemorrhage in animals.
The same authors warned that these materials can
interfere with graft healing and even accelerate graft
occlusion (75). In contrast, Humphries et a:. (36)
obtained encouraging results in dogs. Prostheses
presealed with insoluble collagen were com;>letely
organized by fibrous tissue within eight months of
surgery. The pseudointima had replaced all but a
few of the original bovine collagen fibrils and foci
of endothelium were also observed. By comparing
porous knitted grafts treated with insoluble collagen
(cross-linked with glutaraldehyde) and presealed
grafts in which collagen was cross-linked less
strongly with formaldehyde , Jonas et al. ( 38 , 39)
concluded that the delayed resorption of the sealant,
because of excessive cross-linking, results in an
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Fig .1. TE M of a knitted Dacron graft implanted
in the sheep carotid seven days after implantation.
At the anastomoses, the hyperplastic response is
composed of undifferentiated mesenchymal cells
(arrows), activated smooth muscle cells (arrowheads),
fibroblasts (white arrows) and blood cells (bent
arrows); bar = 5 micrometers.
Fig. 2. SE M of a knitted Dacron graft implanted
in the sheep carotid. After two months, the luminal
opening of a neovascular channel is clearly observed.
Note the continuity in the endothelial lining; bar =
100 micrometers.
Fig .3. SEM of a gelatin sealed knitted Dacron
graft; bar = 100 micrometers.
Fig .4. SEM (a) and TEM (b) of a gelatin sealed
Dacron graft implanted in the sheep carotid. By 4
months, the graft surface is evenly lined by endothelial cells; bars a) = 50 micrometers, b) = 1
micrometer.
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undesirable lack of adhesion between the pseudo intima and the luminal surface of the prosthesis.
This may generate early graft failure due to large
areas of hemorrhagic dissection.
Heat-denatured forms of collagen, namely gelatin, have been proposed for precoating Dacron knitted grafts (Fig. 3). Jonas et al. (40) reported that
after 6 months both rat subcutaneous and canine circulatory implants reveal rapid and complete gelatin
adsorption without undesirable modification of the
normal healing process of knitted Dacron. In our
experience gelatin sealed knitted Dacron grafts are
also suitable as small caliber arterial substitutes
(52). Sixteen grafts (knitted Dacron Triaxial, 8;
knitted Gelseal, 8) of 6 mm diameter were inserted
with end to end anastomoses into both the common
carotid arteries of 8 young sheep. Multiple specimens (distal and proximal anastomoses, central portion of the graft) were retrieved at 1, 2, 8 and 16
weeks after surgery. The combined light and electron microscopic (TEM and SEM) investigation along
with the immunogold labelling technique clearly dem onstrated that bovine gelatin impregnation did not
interfere with the neointima generation. Gelatin was
reabsorbed within 2 weeks of surgery. A well-developed and thin pseudointima, composed of modified
smooth muscle cells and fibroblasts embedded in a
loose extracellular matrix, was observed eight weeks
after implantation. By 4 months, Gelseal grafts were
evenly lined by endothelial cells (Fig. 4a, b) placed
on layers of mainly synthetic smooth muscle cells
(Fig. 5) as well as myofibroblasts. In this experimental design, endothelial cells were mainly provided
by sources at the cut edge of the host arteries. No
significant local inflammatory reaction was encoun tered in the Gelseal Dacron grafts. In contrast, the
contralateral knitted Dacron without gelatin impregnation failed to develop a complete neointimal cover age. Myofibroblasts and fibroblasts were the dominant cells covering these synthetic grafts. It was
therefore concluded that gelatin impregnation was
also useful in promoting the healing process.
Bowald et al. (3, 4) used Vicryl 910 as the
biodegradable component.
Vicryl is a copolymer
consisting of 90% polyglycolic acid and 10% polylactic
acid.
Bowald placed a mesh of Vycril 910 into a
Dacron graft. Four-cm grafts implanted in the aorta
of pigs were endothelialized within 20 days and by
40 days the Vicryl mesh had virtually disappeared.

ferent arterial grafts of varying degrees of porosity
were compared (woven, knitted, light and extra light
knitted Dacron). In no instance was there evidence
of endothelium on the inside of the materials, except
within 10 mm of the suture lines.
In a detailed study, Sottiurai et al. (68) reported a complete pseudointimal lining on Dacron
grafts (both woven and knitted) removed en bloc
during reoperation or amputation. The pseudointima
consisted of fibroblastoid cells orientated parallel to
the direction of the blood flow. The cells were em bedded in a loose extracellular matrix composed of
collagen fibres and amorphous ground substances. In
contrast, ePTFE lacked any organized form of cellu lar coverage, being largely covered by acellular
fibrinous material. Deposition of fibrin on ePTFE
was also reported by Walton et al. (73). Fibrinous
materials within the graft pores appeared, gradually
converted into granulation tissue and later into
fibrous tissue.
Our obser.rations agree with the previous reports (1, 24, 45, 56, 62, 68, 70). Both Dacron and
ePTFE grafts showed a particular form of healing in
humans. This generally consists of the deposition of
proteinaceous materials on the graft surface. This
material organizes giving origin to a continuous sheet
of fibrin in conjunction with blood cells (Fig. 6).
This lining represents the major kind of lining we
observed in humans. In some instances, a capillary
ingrowth was evident in the inner fibrin capsule.
SEM made it possible to demonstrate the surface orifices of the vascular channels in ePTFE grafts next
to the anastomoses (Fig. 7). In contrast with animals, endothelial cells provided by this transmural
source failed to migrate into the surrounding fibrin
mesh except for a few mm. At anastomotic level, a
host cellular reaction (i.e., pannus) composed of myofibroblasts, undifferentiated mesenchymal cells, blood
cells and extracellular matrix was observed. The
pannus growth always had a limited extension towards the graft plane. In addition, a ring - like area
of intimal thickening was frequently encountered especially at the downstream anastomosis. By LM and
TEM, the bulk of the lesion was composed of variously-arranged spindle smooth muscle cells with a
synthetic phenotype. The cells, focally showing a
whorled-liked appearance rest on a loose extracellu lar matrix containing proteoglycans and collagen
fibers. Collagen showed great variability in width
and shape and in some instances displayed a motheaten appearance.

Spontaneous Graft Healing in Humans
For perhaps as long as 20 years, spontaneous
endothelialization of synthetic grafts, as previously
described in animals, was assumed to occur in
humans (7). DeBakey and associates (15) observed
the healing features of 67 patent prostheses recovered from man following implant periods of 2
weeks to almost 7 years. Most of the grafts failed
to organize the inner fibrinous capsule since their
surface appeared homogenously covered by fibrin. In
contrast, endothelium was believed to occur in some
specimens.
In 1964 Wesolowoski (76) stated that "unlike the
pig and the dog, the human does not heal the inner
capsule completely prior to the onset of intercapsular
tuft degeneration". In accordance with this statement, Berger et al. clearly demonstrated graft failure
to develop any endothelial coverage in man (1). Dif-

Endothelial Seeding in Animals
For more than a decade, endothelial seeding has
been understood as the preparation of vascular prostheses by seeding with endothelial cells taken from
other vascular districts. The first experiment was
carried out by Herring (28), who in 1978 described
the possibility of obtaining endothelial cells by
mechanical scarification of the saphena intima and
then seeding these cells on Dacron prostheses.
These prostheses, implanted in dogs, were compared
with control, unseeded prostheses after 2, 4 and 8
weeks. The results emphasized the minor thrombogenicity and minor thickness of the neointima of the
seeded prostheses as compared to the control prostheses.

354

Healing of Synthetic Grafts

Fig. 5. TE M of a gelatin sealed Dacron graft
implanted in the sheep carotid. Four months after
implantation, the synthetic smooth muscle cells are
the major cell component of the neointima; bar = 2
micrometers.
Fig.6. SEM of a human ePTFE femoral popliteal
bypass. After 21 months, the surface is still coated
with fibrin, erythrocytes, and leukocytes. Note the
adhesion (arrows) of endothelial or pseudoendothelial
cells to the underlying macrophages; bar = 10 micrometers.
Fig. 7. SEM of a human ePTFE femoral popliteal
bypass. After 6 months, the transmural capillaries
fails to provide endothelial cells; bar = 300 micrometers.
Fig. 8.
TE M of collagenase harvested human
fat-derived microvessel endothelial cells. The cells
are still clustered by tight junctions (arrow).
Weibel-Palade bodies are clearly observed (arrowhead); bar = 2 micrometers.
Fig .9. SEM of enzymatically harvested human
mesothelial cells.
The cells are spreaded onto a
fibronectin-coated glass surface; bar = 10 micrometers.
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As an alternative to the so-called mechanically
harvested endothelium, Graham, in 1980, proposed the
enzymatic derived endothelium technique (20), which
allows the detachment of the endothelial cells from
the vessel wall by successive enzymatic washings
with trypsin and/or collagenase. This method was
shown to be effective both as regards quality and
quantity and it established itself as the technique of
choice. Subsequent modifications were made to this
technique by Sharefkin (64) and Bourke (2).
As an alternative to the medium -large sized
veins which were originally used as a source of
endothelial cells (21, 28, 31, 35), Williams et al. (78,
79) proposed the extraction of endothelial cells from
the microcirculation of the adipose tissue (Fig. 8).
In addition, Clarke and Pitillo (10, 11) demonstrated
that mesothelial cells (Fig. 9) extracted from dog
omentum have the capacity to form a functional,
non-thrombogenic lining for prosthetic grafts.
The identification of the endothelial cells was
made possible by observing Weibel-Palade bodies at
transmission electron microscopic level or using im munofluorescent staining for Factor VIII-related antigen (7, 28, 78, 79). The immuno-gold labelling approach for detecting the Factor VIII-related antigen,
the glycoprotein Ilb /Illa, moieties for the 1-fucose
and cytoskeletal antigens (i.e., actin, vimentin) was
also used at ultrastructural level (14).
Another important aspect is the quantity of
endothelial cells which can be collected from the
donor tissue for an adequate lining of the prosthesis.
Herring (29) calculated that the maximum quantity of
endothelial cell harvest is 25xlo4 cells/cm2 of vein.
McCall saw that a minimum cell density of 2 .5x104
cells/cm2 was necessary to develop a confluent
growth of pig aorta endothelial culture on ePTFE
membrane, after 5 days (47).
On the other hand, Rosenman (60) claims that
endothelial cell growth in culture is essential for
successful seeding. Using culture media with endo thelial cell-derived growth factor and heparin, Jarrel
(37) succeeded in producing 1000 cm2 of confluent
endothelial cells in 12 days from one cm2 of vessel
wall. This permitted the seeding of vascular prostheses with high density of endothelial cells.
Burkel (5) stressed the importance of morphological investigation to evaluate the success of
seeding. He studied Dacron prostheses in dog, making observations between the first and twentyeighth day after implant. There is no difference between the seeded and control prostheses immediately
after the clot. The prostheses are completely infiltrated with fibrin and blood cells. After one day
the prostheses are covered by a layer of activated
platelets and leukocytes. A few endothelial cells can
be seen between the threads of the seeded prostheses.
A differentiation between the control and
seeded prostheses becomes visible after 4 days. In
the seeded grafts these are patches of immature
endothelial cells without a basal lamina but resting
on a layer of fibrin. After 7 days the control prostheses continue to be covered with fibrin, platelets
and leukocytes. In contrast, the seeded prostheses
show patches of endothelial cells with distinct junc tions and lysis of the subendothelial fibrin mesh.
Clear differences can be seen after 14 days when, in
the control prostheses, 75% of the lumen is occupied
by thrombotic material of varying thicknesses. On
the contrary, the seeded prostheses appear to be al-

most completely free from thrombus and 60% of the
surface is lined with endothelium, below which
smooth muscle cells and fibroblasts can be seen. In
some parts, the prostheses appear to be completely
encorporated by a fibrous capsule. On the outside
foreign body giant cells can be seen, together with
dense connective tissue and numerous capillaries.
After 28 days post-implantation the seeded prostheses
are 80% lined with endothelium as compared to 10%
in the control prostheses.
In the seeded grafts the endothelial cells have
junctional complexes and basal lamina. The subendothelial connective tissue consists of smooth muscle
cells, collagen and fibroblasts.
Vessels can be
clearly seen, penetrating through the prosthetic wall.
Basically, whereas in the control prostheses there is
a simple reorganization of the fibrin clot and a perianastomotic endothelialization, in the seeded prostheses, besides an almost complete endothelialization, a
subendothelial layer is formed, consisting of smooth
muscle cells. These observations were also confirmed
in other experimental models (6, 66).
The morphological data are flanked by a whole
series of functional studies on the efficacy of endothelial seeding which improves the survival of platelets and decreases the release of platelet serotonin
(7, 9, 23). Moreover, the endothelial cells maintain
the capacity for prostacycline synthesis (23, 65).
Following the first experiments using Dacron
protheses, the possibility of treating ePTFE with
endothelial seeding was also examined. Graham, in
1982, in a dog model, seeded ePTFE prostheses 6-10
mm in diameter and 20-30 mm long with endothelial
cells (21). In this case also, endothelialization by
seeding appeared to be more rapid and complete than
unseeded prostheses. Indeed, after 4 weeks, 91% of
the surface of seeded prostheses was lined with
endothelial cells, whereas in the control prostheses
endothelialization did not arrive at more than 7 mm
from the anastomoses. In addition, Graham observed
some peculiar differences between the healing of
seeded ePTFE and seeded Dacron. ePTFE, indeed,
appeared to be less reactive to blood components.
The inner capsule appears to be thinner, and there is
less infiltration and incorporation by the leukocytes.
One characteristic feature observed was that in
seeded ePTFE the endothelial monolayer was not reg ularly supported by a subendothelial tissue; in par ticular, unlike seeded Dacron, no smooth muscle cells
were observed. These differences can be attributed
to the differences in the chemical structure, in configuration and above all in the permeability of
Dacron and ePTFE. In addition, Miller et al. (49)
demonstrated that although both Dacron and ePTFE
were efficient in the macrophage activation, Dacron
surface had a greater density of activated cells corresponding to elevated levels of interleukin-! in
cultures.
Herring (32) compared the two types of prostheses with controls after 7 months and confirmed
the good endothelialization capacity of seeded ePTFE,
which appeared to be more rapid than in seeded
Dacron. The importance was emphasized of the thinner inner capsule in ePTFE as compared to Dacron
(22 ± 32 micrometers vs 169 ± 143 micrometers).
This depends in particular on the low porosity of
ePTFE (internodal distance 30 micrometers) which
hinders the transparietal diffusion of cellular elements (myofibroblasts and smooth muscle cells) and
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the formation of vasa vasorum. Herring attributed
the minor tendency of seeded ePTFE to develop a
myointimal hyperplasia to these characteristics.
According to other authors ( 41), the absence of
a subendothelial structure does not favour a stable
and well functioning endothelium ; it is thus suggested
that ePTFE prostheses with a greater porosity should
be used (internodal distance 45 micrometers).
Although the results reported are encouraging,
Hollier (35) raises doubts as to the origin of the
endothelial lining in seeded protheses. He made a
study in male pigs, seeding prostheses with endothelial cells collected from female pigs.
After 4
weeks the implanted prostheses appeared to be lined
with endothelial cells with male karyotype, thus
excluding successful seeding.
The possibility of staining the seeded endothelial cells with indiumlll was explored by
Rosen man ( 60), with the intention of quantifying
over time the presence of cells seeded on a vascular
prosthesis once the blood flow had been re-established. The result was that after 24 hours only a
small part of the seeded endothelial cells were present on the prosthesis. In the first thirty minutes
after restoration of blood flow there is a rapid loss
of endothelial cells. This is followed by a stage,
from 30 minutes to 24 hours, in which the endothelial cells are lost at a slower but constant rate so
that at 24 hours only 17% of the endothelial cells
adhering at the beginning remains.
However,
Patterson et al. (53) demonstrated the spontaneous
loss of indiumlll from isolated canine endothelial
cells.
It was therefore suggested that indiumlll
oxine labeling is not a reliable technique for the
study of endothelial cell kinetics in vivo. Recently,
some authors (50, 80) used recombinant retroviruses
to transduce beta- galactosidase genes into harvested
endothelial cells. This technology appears particularly suitable in order to estimate the presence of
seeded endothelial cells on vascular substrates.
A problem thus emerges of great importance for
the success of seeding: how to improve the adhesion
of the seeded endothelial cells to the prosthetic
material.
In the first place, several methods of endothelial seeding have been proposed to improve seeding
efficacy. Kesler ( 43) suggested sequential inoculation; Faso! (17), uses a rotation device; Shindo (67)
seeds the endothelial cells on prostheses in a glassware apparatus for 48-72 hours before implanting.
At the same time, research in the field of prosthetic substratum has been developed. The precoating of material with fibronectin has been shown to
be very effective, starting with the first experiments
by Kempczinski and Ramalanjaona (42, 55). This
method increases the adhesion of the seeded endothelia l cells, reducing their loss once blood flow has
been restored.
Our approach was designed to analyze the interaction between endothelial cells and various synthetic vascular grafts by means of SEM (14). Endothelial cells were harvested from adipose tissue by
using collagenase treatment. Cell viability, as determined by Trypan Blue exclusion, resulted in higher
than 90% of isolated cells. Endothelium was characterized by the demonstration of positivity for Factor
VIII-related antigen and glycoprotein lib/Illa. Endothelial cells were seeded and left to adhere for one
hour onto different synthetic grafts. As expected,

knitted Dacron and ePTFE alone are not suitable for
generating endothelial cell monolayers. In fact, SEM
showed no cell adhesion on these substrates. Blood
preclotting did not significantly improve the rate of
c ell adhesions and basically resulted in the presence
of areas with cell attachments. Commercially available coated grafts (Gelseal Dacron, Albumin-coatedDacron, Hemashield Dacron) were further investigated. Interesting results were obtained with gelatin-coated Dacron (Gel seal).
In agreement with
other authors (27), we found that gelatin permits the
adhesion of seeded endothelium. A high density of
adherent endothelial cells was seen on the Gelseal
surface even though the rate of cell spreading was
low (Fig. 10). Adherent cells were mainly round in
shape.
However, many cells showed thin filopodia
while others exhibited complex surface corrugations.
A few spread cells were also found. In our experiments these results were not constant; this most
likely depends on variations in the physico-chemical
characteristics of the gelatin contained in different
industrial supplies (14). In contrast, Albumin-coatedDacron and Hemashield Dacron (sealed with type I
collagen) did not seem to favor endothelial cell
adhesion. In particular, Albumin-coated grafts lacked
endothelial coverage while Hemashield Dacron showed
an intermediate behavior. By SEM, clusters of endothelium were observed particularly in the hollows of
the material.
These results do not comply with
those reported in experimental models ( 54) and in
animal models (67) utilizing collagen-coated-Dacron.
However, this discrepancy could be attributed to the
fact that Shindo et al. (67) impregnated their prostheses with a mixture of 1/111 type collagen. In our
experience, the best results are provided by adsorbed
ePTFE grafts with bioactive molecules. As previously
described, ePTFE alone did not permit any cell adhesion. However, incubation of ePTFE with 20 mg/cm2
of fibronectin for 2 hours at 37°C resulted in a
dense lining of seeded endothelial cells (20-29 cells/
micrometers2) with a significant tendency to spread
out (Fig. 11). The exposure of endothelial cells to
this substrate induced rapid cell morphological
changes. Endothelium lost their round appearance
and extended long, slender filopodia making tenuous
contacts with the substrate. As the endothelial adhesion proceeded, the interaction appeared more stable.
Endothelial cells presented peripheral cytoplasmic flaps and in some areas completely spread
over the substrate. Analogous results were provided
by ePTFE grafts preliminary treated with fibrin-containing mixtures.
SEM examination of fibrin glue
(Immuno AG) coated ePTFE grafts clearly revealed a
sharp transition in cell adhesion between coated and
uncoated ePTFE surfaces (Fig. 12) thus confirming
data provided by Zilla et al. (82).
Finally, the experiments carried out with carbon-coated ePTFE (63) should also be kept in mind.
Endothelial Seeding in Man
The first experiments of endothelial seeding in
man were carried out by Herring (31), who in 1984
reported the results of a trial with implanting of
Dacron prostheses seeded with endothelial cells collected with the mechanical method. The data concern bypasses made in different vascular areas:
axillo-femoral, femoro-femoral and femoro-popliteal;
in this last group the seeded prostheses are also
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Fig. 10. SEM of collagenase harvested human
fat-derived microvessel endothelial cells. After 1 h
of incubation on a gelatin coated Dacron graft, the
density of cell adhesion is high; bar == 100 micrometers.
Fig. 11. SE M of collagenase harvested human
fat-derived microvessel endothelial cells. After one
hour of incubation on a fibronectin-coated ePTFE
graft, there is a good cell adhesion on the substrate.
Spread endothelial cell are also present; bar == 50
micrometers.
Fig.12.
SEM of collagenase harvested human
fat-derived microvessel endothelial cells. After 1 h
of incubation on a fibrin glue coated ePTFE graft,
there is a sharp transition in cell density between
coated and uncoated PTFE surface; bar == 25 micrometers.
compared with the autologous vein. The results assessed on the basis of the patency and the platelet
function, are not the same as those obtained in experiments performed in animals. Although he reports
an improved patency in seeded prostheses of some
sub-groups (femoro-popliteal of non-smokers),
Herring did not, in fact, observe great differences
between seeded and control prostheses.
He did,
however, confirm the validity of the autologous vein.
The small number of histological observations did not
reveal seeded endothelial cells on the prostheses
after 4 months, but only fibroblasts and smooth
muscle cells.
It was Herring again, who made an interesting
morphological observation of seeded ePTFE at 90
days after implant in man (33). Unlike the experience with Dacron, areas of endothelialization could
be recognized in this case, characterized by a monolayer of endothelium-like cells, resting on a thin
layer of matrix with no elastin, collagen or smooth
muscle cells. Given the distance from the anastomo sis of the area examined (10 cm) and the absence of
myofibroblasts, Herring concludes that endothelialization is probably secondary to seeding.
In 1986 in Vienna, the results were presented
of 4 clinical trials carried out in different centres:
Indianapolis, Vienna, Goteborg and Dundee (17, 34,
58, 72). Although there were a few differences due
to the harvesting and seeding techniques employed,
the prosthetic material used and the postoperative
control methods, the various authors concluded that
endothelial seeding in man gives less positive results
than in animals. Although, on the basis of long-term
patency and platelet reactivity, the comparison be tween seeded and control protheses appears to indicate the major healing characteristics of seeded
prostheses; the comparison of data does not reveal
statistically significant differences.
Discussion
Several groups of investigators have described
the clinical and experimental results of graft incorporation using synthetic materials of various designs and compositions (7, 62, 71, 74, 77, 81). Some
reports have also provided detailed and correlated
documentation of the arterial cellular and subcellular
healing responses to graft implants in animals ( 12 ,
13, 54, 56, 59, 70, 77). Most of these papers support
the view that synthetic vascular grafts of both
Dacron and ePTFE fabrics heal through a process of
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graft arterialization which, within certain limits,
seems to recapitulate the normal architecture of the
replaced artery. At the final stage, a continuous
luminal graft repopulation with endothelial cells
and/or modified smooth muscle cells (neointima)
takes place.
As far as graft thrombogenicity is
concerned, this neointimal coverage represents the
ideal blood/graft interface (7, 44, 79).
In contrast to experimental animals, the flow
surface of both Dacron and ePTFE grafts in humans
remains unhealed, with a surface of more or less
compacted, cross-linked fibrin. Healing in humans
consists of outer wall attachment by fibrous tissue.
Further healing of the prosthesis occurs very slowly
and rarely involves the inner wall. This consists of
a thin and relatively stable fibrin lining due to a
critical equilibrium between fibrin neo-deposition and
its degradation by the monocyte/macrophage system.
In addition , endothelium and smooth muscle cells
provided from the arterial sources (anastomoses) migrate only a few mm from the cut edge of the artery
(1, 15, 76).
Patches of cell coverage most likely
related to the graft capillarization remain circumscribed to the luminal openings of the neointimal
c apillaries mainly at the anastomoses and the cells
provided do not extend any further. Therefore, the
usual patterns of graft endothelialization seem to be
ineffective in man. In any case, the luminal fibrin
coverage remains essentially unchanged for months or
even years and appears as a relatively non -thrombogenic lining. In the large conduits, in fact, this
lining seems to be sufficient to minimize graft com plication. In fact, the patency rate of Dacron and
ePTFE grafts is particularly high in the aorto- iliac
position. However, with diameters of 5 mm or less
the failure rate of both these materials is unacceptable.
After 3 months, approximately 30 % of the
grafts are closed by early thrombosis.
After 36
months, only 20 % of artificial grafts are still patent
(7). In this context one of the causes of the lack of
success of artificial prostheses when compared to
autologous vein implants, besides the evident difference in compliance, may be attributed to the lack of
functioning endothelium at the moment of implant.
Therefore, the presence of a continous endothelial
layer should be considered as an essential prerequisite for the success of low -flow, small-diameter
grafts.
The need to favour a rapid and, as far as possible, complete endothelialization of implanted vascular prostheses has induced some researchers to introduce and develop the endothelial seeding technique
(28, 79). The experiments carried out, with various
prosthetic materials in animal, are without doubt
encouraging. From a clinical point of view, seeded
prostheses give immediate patency results and, in the
long run, better results than unseeded prostheses.
From a functional point of view, there is a more effective restoration of the synthetic endothelial ac tivity as well as an improvement in the main platelet
functioning parameters in seeded prostheses.
In
addition, seeding permits an almost complete and
rapid endothelialization of the prosthesis segment
with different aspects linked to the chemico-physical
and structural characteristics of the various materials
studied. The results obtained with endothelial seeding in animals indicate that although the actual capacity of seeded endothelial cells to remain attached
to the prostheses, subject to hemodynamic stress, has

not been clearly established; this method does favour
prosthetic endothelialization.
Equivalent results have not been obtained in
the few experiments carried out in man. It may be
postulated that there are many causes which interfere with the efficacy of endothelial seeding in man.
In the first place, the difficulty of harvesting a
sufficient number of endothelial cells must be considered. To this can be added the need to overcome
the limitations involved in using human endothelial
cultures and the need to find substratum which favour a major adhesion of seeded endothelial cells.
In the second place, along with the well-known differences between species (16), it should be remembered that in a man requiring a prosthetic implant, a
multidistrict steno-obstructive disease is present,
inducing complex variations in the regional hemodynamics. This disease is also maintained and aggravated (70, 73) by the presence of various factors
such as smoking, diabetes, hypertension and hyperlipidemia.
In conclusion, the thirty years of experiments
in the field of synthetic vascular prostheses have
revealed large differences in the results in animal
models and those in human models. In man, while in
the aorto-iliaco - femoral district a fibrin layer appears to be sufficient for long-term patency of such
materials; in small caliber districts an improvement in
compliance and an endothelial lining is essential.
This may be favoured by endothelial seeding. Some
encouraging results in man have been achieved with
this method. The long-term fate of seeded grafts in
man, however, can only be assessed with an increase
in clinical experiences together with the use of more
sophisticated morphological and functional analyses.
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Discussion with Reviewers
K.A. Robinson: What are your criteria for the characterization of syntjetic smooth muscle cells and
their distinction from myofibroblasts at the TE M
level? Clowes et al. (13) have shown that, at least
in ePTFE grafts, the spindle-shaped cells of the neointima were all smooth muscle cells. This may have
significance in terms of extracellular matrix produc tion and any retraction of the intimal thickening.
Authors: According to F. N. Ghadially (Diagnostic
Electron Microscopy of Tumours, Ilnd edition,
Butterworths, London, 1985, pp. 456 - 466.), the
following TEM features were used to distinguish
myofibroblasts from synthetic smooth muscle cells: i)
abundance of elements of the Golgi complex and
rough endoplasmic reticulum; ii) paucity of micropinocytotic vesicles; and iii) absence or relative
infrequency of basal-lamina- like material.
K.A. Robinson: You cite recent work regarding adipose tissue as a source of endothelial cells from
graft seeding. What are the advantages of this technique, particularly with respect to cell yield and
seeded cell density?
Authors:
The major advantages of this technique
are: 1) large quantity of endothelial cells are rapidly
(2-4 hr) available (average yield: 104-106 cells/g fat
tissue); ii) reproducibility in yield; iii) high endothelial cell yield for immediate monolayer generation;
and iv) large vessels for cell procurement are spared.
K.A. Robinson:
Could the divergent healing responses of experimental animals and humans be due
in part to discrepance in relative age? Perhaps a
greater regenerative capacity is seen in the former
because relatively young animals are used.
Authors: Yes, we agree with your comment.
K .A. Robinson: Another possible reason for graft
failure may be cytokine stress from adherent leukocyte (Fig. 6). Could you comment on the role of
chronic inflammation in graft failure?
Authors: Interleukin - 1 (IL - 1) and tumor necrosis
factor (TNF) are important cytokines produced by
activated mononuclear cells. They share many biologic properties and also act synergistically.
In
particular, IL-1 and TNF produce local effects on
endothelium which may be relevant to the process of
graft failure. IL-1 and TNF induce on endothelium
the synthesis of surface adhesion molecules, which
stimulate increased adhesion of inflammatory cells to
the endothelium. They stimulate the endothelial cell
synthesis of platelet activating factor, which is a
powerful platelet activator and aggregator.
They
produce an increase in procoagulant and a decrease
in anticoagulant properties of endothelial cells, rendering the endothelial surface potentially thrombogenic.

362

